Abate Kristin, Chief Accounting Officer at Karyopharm Therapeutics Inc. ($KPTI), sold shares on the open market seven times over the last 365 days for a total of about $10,651. Her most recent sale occurred on March 2, 2026. These sales rank her 11,260th among 11,678 individual insiders by total value sold, well below the average of $8.6 million per insider and 6.4 transactions. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Karyopharm Therapeutics Inc. | $KPTI | Abate Kristin | Chief Accounting Officer | S | Common Stock | 559 | $9.41 | 22,063.0000 | 18,343,968 | 2.47% | 0.00% |
| Jan. 28, 2026 | Karyopharm Therapeutics Inc. | $KPTI | Abate Kristin | Chief Accounting Officer | S | Common Stock | 50 | $7.03 | 22,622.0000 | 17,050,876,000 | 0.22% | 0.00% |
| Jan. 27, 2026 | Karyopharm Therapeutics Inc. | $KPTI | Abate Kristin | Chief Accounting Officer | A | Common Stock | 92 | $0.00 | 22,672.0000 | 17,050,876,000 | 0.41% | 0.00% |
| Jan. 21, 2026 | Karyopharm Therapeutics Inc. | $KPTI | Abate Kristin | Chief Accounting Officer | S | Common Stock | 265 | $5.96 | 22,580.0000 | 17,050,876,000 | 1.16% | 0.00% |
| Oct. 15, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Abate Kristin | Chief Accounting Officer | A | Common Stock | 12799 | $0.00 | 22,845.0000 | 126,240,054 | 127.40% | 0.01% |
| Oct. 1, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Abate Kristin | Chief Accounting Officer | S | Common Stock | 362 | $6.30 | 10,046.0000 | 126,240,054 | 3.48% | 0.00% |
| Sept. 12, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Abate Kristin | Chief Accounting Officer | A | Common Stock | 46 | $0.00 | 10,431.0000 | 126,240,054 | 0.44% | 0.00% |
| Sept. 15, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Abate Kristin | Chief Accounting Officer | S | Common Stock | 23 | $6.43 | 10,408.0000 | 126,240,054 | 0.22% | 0.00% |
| Sept. 3, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Abate Kristin | Chief Accounting Officer | S | Common Stock | 12 | $6.78 | 9,463.0000 | 126,240,054 | 0.13% | 0.00% |
| July 22, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Abate Kristin | Chief Accounting Officer | S | Common Stock | 238 | $4.00 | 9,475.0000 | 126,240,054 | 2.45% | 0.00% |
| March 4, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Abate Kristin | Chief Accounting Officer | S | Common Stock | 571 | $6.29 | 9,713.0000 | 126,240,054 | 5.55% | 0.00% |
| Feb. 28, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Abate Kristin | Chief Accounting Officer | A | Stock Option (right to buy) | 1866 | $0.00 | 1,866.0000 | 126,240,054 | 9999.99% | 0.00% |
| Feb. 28, 2025 | Karyopharm Therapeutics Inc. | $KPTI | Abate Kristin | Chief Accounting Officer | A | Common Stock | 933 | $0.00 | 10,284.0000 | 126,240,054 | 9.98% | 0.00% |